Saizen® [somatropin (rDNA origin) for injection] is indicated
for the treatment of children with growth failure due to
growth hormone deficiency and in adults with growth hormone deficiency.
Saizen®
is contraindicated in patients with a known sensitivity to growth hormone,
diabetic retinopathy, acute
critical illness in the presence of active malignancy, and in patients
with Prader-Willi syndrome who are severely
obese or have severe respiratory impairment.
Saizen® should be used with
caution in patients with insulin resistance, glucose intolerance, diabetes,
hypothyroidism, intracranial hypertension, and in women who are pregnant
or nursing. Although infrequent,
delivery site reactions may occur.
This Web site contains medical information intended for
residents of the United States only.
This site was developed
by EMD Serono, Inc. (emdserono.com) to
educate patients and interested healthcare
professionals about easypod® and Saizen® treatment for growth hormone
deficiency.
This information is not intended to replace discussions
with your healthcare professional. For additional information
about Saizen®, please read the Saizen®
Full Prescribing Information and
the easypod® and click.easy® Instructions
for Use
and talk to your healthcare professional. You can also call Connections
For Growth® toll free at 800/582-7989,
or visit www.saizenus.com.
Saizen®, click.easy®, and easypod® are available by
prescription only.
Only your healthcare professional can prescribe Saizen® and easypod®.
Use
and access of this site is subject to terms and conditions as set forth
in our
Legal Statement and Privacy
Policy. |
